Nevirapine Suspension
Product Images NDC 65862-057

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 65862-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mosteller Formula (Nevirapine Fig1)

A text panel displaying the Mosteller formula for calculating body surface area (BSA) in square meters. The formula is given as the square root of the product of height in centimeters and weight in kilograms divided by 3600.*

FDA Label Image

Package Label.principal Display Panel (50 mg/5 mL (240 mL Bottle))

Label for Nevirapine Oral Suspension, USP, 50 mg/5 mL, 240 mL bottle. The label indicates it is a prescription drug by Aurobindo Pharma USA, Inc., made in India. It includes storage instructions, a warning to keep out of children's reach, and a note to shake gently before use. The NDC 65862-057-24 and barcode are also present.*

FDA Label Image

Chemical Structure (Nevirapine Str)

Chemical structure of Nevirapine, displaying its bicyclic ring system with attached methyl, nitrogen, and cyclopropyl groups as depicted in the image for the 50 mg/5 mL oral suspension by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.